Patents by Inventor Michael Nardi

Michael Nardi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE REGIMES FOR ANTI-CD73 AND ANTI-ENTPD2 ANTIBODIES AND USES THEREOF
    Publication number: 20240141060
    Abstract: The invention generally relates to dosage regimes of anti-Cluster of Differentiation 73 (CD73) antibodies and/or anti-ectoenzyme ectonucleoside triphosphate diphosphohydrolase 2 (ENTPD2) antibodies, used in methods of treatment of cancer in a subject, as well as dosage regimes of anti-CD73 antibodies for use in treating cancer. The invention further generally relates to dosage regimes of combinations of agents, such as combinations comprising anti-CD73 antibodies and/or anti-ENTPD2 antibodies and at least one or more of a PD-1 inhibitor, and an adenosine A2AR antagonist.
    Type: Application
    Filed: January 27, 2022
    Publication date: May 2, 2024
    Inventors: Juan Gonzalez-Maffe, Randi Ellen Isaacs, Jaeyeon Kim, Lisa Nardi, Javier Alberto Otero, Nehal Parikh, Michael John Roy, Kulandayan Kasi Subramanian, Tingting Zhai
  • Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders
    Patent number: 8753631
    Abstract: The present invention is directed to a therapeutic agent comprising a GPIIIa(49-66) specific targeting agent and a thrombi-specific homing agent. Also disclosed is the use of the therapeutic agent in carrying out a method of treating thromboembolic disorders and a method of inducing platelet fragmentation.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: June 17, 2014
    Assignee: New York University
    Inventors: Simon Karpatkin, Michael Nardi, Zongdong Li
  • AGENTS THAT DISSOLVE ARTERIAL THROMBI
    Publication number: 20110052594
    Abstract: Agents that induce platelet fragmentation include an IgG antibody that reacts with platelet epitope GPIIIA49-66 on platelet membrane, recombinant AMANTS-18, phorbol 12-myristate 13-acetate (PMA) and A23817.
    Type: Application
    Filed: February 11, 2009
    Publication date: March 3, 2011
    Applicant: NEW YORK UNIVERSITY
    Inventors: Simon Karpatkin, Michael Nardi
  • THERAPEUTIC AGENTS FOR INDUCING PLATELET FRAGMENTATION AND TREATING THROMBOEMBOLIC DISORDERS
    Publication number: 20110045008
    Abstract: The present invention is directed to a therapeutic agent comprising a GPIIIa(49-66) specific targeting agent and a thrombi-specific homing agent. Also disclosed is the use of the therapeutic agent in carrying out a method of treating thromboembolic disorders and a method of inducing platelet fragmentation.
    Type: Application
    Filed: April 30, 2010
    Publication date: February 24, 2011
    Applicant: NEW YORK UNIVERSITY
    Inventors: Simon Karpatkin, Magaret Karpatkin, Michael Nardi, Zongdong Li
  • Agents that dissolve arterial thrombi
    Publication number: 20070009529
    Abstract: Agents that induce platelet fragmentation include an IgG antibody that reacts with platelet epitope GPIIIA49-66 on platelet membrane, recombinant AMANTS-18, phorbol 12-myristate 13-acetate (PMA) and A23817.
    Type: Application
    Filed: June 22, 2006
    Publication date: January 11, 2007
    Applicant: New York University
    Inventors: Simon Karpatkin, Michael Nardi
  • Antibodies that dissolve arterial thrombi
    Publication number: 20040236079
    Abstract: An IgG antibody which induces platelet fragmentation. The antibody reacts with platelet epitope GPIIIa49-66 on platelet membranes. This antibody, or a monoclonal antibody derived from the GPIIIa49-66 epitope, will dissolve arterial thrombi generally found in the coronary arteries of patients with acute myocardial infarction as well as other arterial occlusions.
    Type: Application
    Filed: July 20, 2004
    Publication date: November 25, 2004
    Inventors: Simon Karpatkin, Michael Nardi
  • Orange tree name ‘Villa11’
    Patent number: PP33249
    Abstract: A new orange tree named ‘Villa11’ characterized by its late-maturing fruit.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: July 13, 2021
    Inventors: Frank Mercuri, Domenic Mercuri, Frank Nardi, Michael Nardi, Joe Nardi